Get started
Author

Milton B. Dobkin

Observed names: M B Dobkin, M. B. Dobkin, M. Dobkin, M.B. Dobkin, Milton B Dobkin
OpenAlex ID: A5078820021
Comparison of varicella zoster antibody titers in patients given intravenous immune serum globulin or varicella zoster immune globulin
1984 · S.G. Paryani, A.M. Arvin, et al. · The Journal of Pediatrics · 49
Antibody Response to a Human Diploid Cell Rabies Vaccine
1974 · V. J. Cabasso, M. B. Dobkin, et al. · Applied Microbiology · 49
Pasteurization of antihemophilic factor and model virus inactivation studies
1985 · Paul K. Ng, Milton B. Dobkin · Thrombosis Research · 41
Characterization of Subviral Components Resulting from Treatment of Rabies Virus with Tri(n-butyl) Phosphate
1972 · A. R. Neurath, S. K. Vernon, et al. · Journal of General Virology · 39
Measurement of rabies antibody: comparison of the mouse neutralization test (MNT) with the rapid fluorescent focus inhibition test (RFFIT)
1975 · R.E. Louie, M.B. Dobkin, et al. · Journal of Biological Standardization · 34
Varicella zoster antibody titers after the administration of intravenous immune serum globulin or varicella zoster immune globulin
1984 · Sharon G. Paryani, Ann M. Arvin, et al. · The American Journal of Medicine · 19
Antibody levels in reduced/alkylated intravenous immune globulin
1984 · Ralph H Rousell, Michael S Collins, et al. · The American Journal of Medicine · 17
Inactivation of viruses in therapeutic products derived from human plasma
1988 · Gautam Mitra, Milton B. Dobkin, et al. · The American Journal of Medicine · 7
Inactivation of Viruses with 1,10-Phenanthroline
2015 · K. J. Lembach, M. B. Dobkin, et al. · Current studies in hematology and blood transfusion · 3
Transmission of Hepatitis After the Administration of Intravenous Immunoglobulins
1993 · Ralph H. Rousell, Milton B. Dobkin, et al. · American Journal of Clinical Pathology · 3
Process-Scale Purification of Immunoglobulin M Concentrate
1993 · Paul K. Ng, Peter E. O'Rourke, et al. · Vox Sanguinis · 3
Virus Inactivation/Elimination in Therapeutic Protein Concentrates1
2015 · G. Mitra, M. B. Dobkin, et al. · Current studies in hematology and blood transfusion · 2
Hepatitis A Viral Safety of Plasma‐Derived Factor VIII Concentrate Koate®‐HP
1994 · G. Mitra, M. Dobkin, et al. · Vox Sanguinis · 2
Virucidal efficacy of saturated intermediate length straight-chain alcohols in biologically active protein solutions
1991 · Milton B. Dobkin, George B. Dove, et al. · Biologicals · 1
Characterisation and virus safety of alpha 1-proteinase inhibitor.
1990 · M H Coan, M B Dobkin, et al. · PubMed · 1
Antibody levels following WI38 rabies vaccine.
1978 · V J Cabasso, R E Louie, et al. · PubMed · 1
Hepatitis A Viral Safety of Plasma-Derived Factor VIII Concentrate Koate�-HP
2015 · G. Mitra, M. Dobkin, et al. · KARGER eBooks
Hepatitis A Viral Safety of Plasma-Derived Factor VIII Concentrate Koate®-HP
1994 · G. Mitra, M. Dobkin, et al. · Vox Sanguinis
Works count: 18
Citation count: 271
H-index: 7
I10-index: 7
Year
Topic
Type